Wealth Collab, LLC Alkermes Plc. Transaction History
Wealth Collab, LLC
- $136 Billion
- Q2 2024
A detailed history of Wealth Collab, LLC transactions in Alkermes Plc. stock. As of the latest transaction made, Wealth Collab, LLC holds 406 shares of ALKS stock, worth $10,681. This represents 0.01% of its overall portfolio holdings.
Number of Shares
406
Previous 406
-0.0%
Holding current value
$10,681
Previous $11 Million
-0.0%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding ALKS
# of Institutions
349Shares Held
183MCall Options Held
209KPut Options Held
89.4K-
Black Rock Inc. New York, NY29.1MShares$766 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA20MShares$526 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA14.4MShares$378 Million0.06% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD11MShares$290 Million0.03% of portfolio
-
State Street Corp Boston, MA9.22MShares$242 Million0.01% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $4.32B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...